Mundipharma International Limited (MINT) and its independent associated companies are committed to improving the health and quality of life of people everywhere. Over the last 50 years, our associates have become leaders in pain management, developing new drugs and patented formulations to relieve chronic pain for patients and to help them improve their lives. As we move forward, we are building a presence in oncology and respiratory treatments to help transform the lives of even more patients. MINT plays a dynamic key role in leading multidisciplinary support for the Mundipharma / Napp / Norpharma independent associated companies across Europe.

Within the independent associated companies, employees are encouraged to achieve excellence in all fields: research and development, manufacturing and sales and marketing functions. We strive to be the very best we can be. Within MINT, we have an open, dynamic, entrepreneurial culture where you have the freedom to define and achieve your own success.

MINT and its independent associated companies have a strong heritage of recognition for our culture, environment and investment in people. This has been recognised within our associate companies in several countries, including placement three years running in "The Times Best 100 Places to Work" in the UK. In a similar survey of Austria’s best employers, Mundipharma is the highest ranked pharmaceutical company in the history of the survey.

Through these combined attributes, we have achieved tremendous success and will continue to strive for excellence in the future. The strength of our research, the passion and commitment of our people and our firm foundations provide the platform to continue to bring innovative medicines to those patients that suffer on a daily basis.

Knowledge, the freedom to think differently and a firm commercial focus are the perfect combination for us – it’s the reason why we are so confident about future growth